Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ATI-2231 |
Trade Name | |
Synonyms | ATI2231|ATI 2231 |
Drug Descriptions |
ATI-2231 inhibits MAPKAPK2 (MK2), potentially resulting in decreased downstream signaling, impaired DNA damage repair, and tumor cell apoptosis (J Bone Oncol 45 (2024): 100569, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200127 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATI-2231 | ATI-2231 | 0 | 1 |
ATI-2231 + Capecitabine | ATI-2231 Capecitabine | 0 | 1 |